FindTrial
Sign In

Study on the predictive value of sperm DNA integrity testing (SCSA) for reproductive outcomes in assisted reproductive therapy

Study on the predictive value of sperm DNA integrity testing (SCSA) for reproductive outcomes in assisted reproductive therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098253
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-02-08
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility

Interventions

Observation group:none

Sponsors

Department of Reproductive Medicine, General Hospital of Eastern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Couples have normal sexual life without contraception for more than 1 year, and the wife is not pregnant; 2. Both husband and wife have normal chromosomes, no family history of genetic diseases, no endocrine, and anatomical factors abnormal.

Exclusion criteria

Exclusion criteria: 1. The wife suffered from endometriosis, uterine fibroids, endometritis and other diseases affecting the implantation of embryos; 2. Acute infection of male genitourinary system; 3. severe oligospermia of male; 4. The husband performs epididymal puncture, testicular puncture to extract sperm, or needs frozen sperm for in vitro fertilization; 5. The husband is diagnosed azoospermia, which needs sperm donor treatment.

Design outcomes

Primary

MeasureTime frame
sperm DNA integrity;—

Countries

China

Contacts

Public ContactYao Bing

General Hospital of Eastern Theater Command

yaobing@nju.edu.cn+86 25 8086 4614

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026